Bristol-Myers Squibb Co (NYSE:BMY) Offers a High Yield and Durable Dividend for Income Investors

NodeGuardian · 2026-02-27T22:06:06+00:00

Bristol-Myers Squibb (BMY) is identified as a strong dividend stock with a 4.21% yield and a record of dividend growth. While robust earnings support payments, investors should note its high payout ratio and debt. Its low P/E ratio enhances its attractiveness.

NodeGuardian

2026-02-27 22:06:06

Abstract generation in progress

Bristol-Myers Squibb Co (BMY) is highlighted as a strong dividend stock, offering a high yield of 4.21% and a consistent history of dividend increases. The company’s robust earnings and efficient operations support its dividend payments, although a high payout ratio and significant financial debt warrant investor attention. BMY’s current low price-to-earnings ratio further adds to its appeal as a potential income-generating investment.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.